CorVel Corp. (NASDAQ:CRVL – Get Free Report) Director R Judd Jessup sold 1,562 shares of the company’s stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $70.71, for a total transaction of $110,449.02. Following the transaction, the director owned 117,083 shares of the company’s stock, valued at $8,278,938.93. This represents a 1.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
R Judd Jessup also recently made the following trade(s):
- On Thursday, August 27th, R Judd Jessup sold 1,262 shares of CorVel stock. The shares were sold at an average price of $70.64, for a total value of $89,147.68.
CorVel Stock Down 0.3%
CRVL stock opened at $69.24 on Friday. The company has a market capitalization of $3.53 billion, a P/E ratio of 30.77 and a beta of 0.98. The company has a 50-day simple moving average of $63.41 and a 200 day simple moving average of $58.22. CorVel Corp. has a fifty-two week low of $44.83 and a fifty-two week high of $93.45.
Institutional Trading of CorVel
A number of institutional investors have recently added to or reduced their stakes in CRVL. BlackRock Inc. acquired a new position in shares of CorVel in the 2nd quarter valued at $321,316,000. California State Teachers Retirement System boosted its position in shares of CorVel by 7,962.8% during the 2nd quarter. California State Teachers Retirement System now owns 2,350,314 shares of the business services provider’s stock valued at $146,942,000 after acquiring an additional 2,321,164 shares in the last quarter. Norges Bank bought a new stake in CorVel in the fourth quarter valued at about $29,250,000. Bank of New York Mellon Corp bought a new stake in CorVel in the second quarter valued at about $11,439,000. Finally, Algert Global LLC raised its position in CorVel by 67.0% in the second quarter. Algert Global LLC now owns 383,419 shares of the business services provider’s stock worth $23,971,000 after purchasing an additional 153,877 shares in the last quarter. 51.36% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
CRVL has been the subject of a number of recent analyst reports. Weiss Ratings raised shares of CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 16th. Wall Street Zen raised shares of CorVel from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, CorVel has a consensus rating of “Hold”.
Check Out Our Latest Research Report on CorVel
CorVel Company Profile
CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.
The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).
Featured Stories
- Five stocks we like better than CorVel
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
